AstraZeneca and Gilead both reported successful trials in a hard-to-treat form of breast cancer, sparking a debate about ...

In a case that was billed as profits versus patients, India’s Supreme Court dismissed a petition in which Roche sought to ...

A new study suggests that these vaccines might boost the effects of immunotherapy drugs, perhaps by alerting the immune ...

Enhertu can help patients with breast cancer when given earlier in the disease, according to data presented at the ESMO ...

Roche and Celcuity each detailed positive advanced breast cancer trials at ESMO 2025, studies that could lead to new ...

Public health leaders “have to figure out how to reach” those who are open to persuasion on vaccines and more, says former ...

Grail announced fresh data on Friday from a large U.S. study of its flagship Galleri blood-based test for detecting dozens of ...

Last month, Joe Kennedy III called on his uncle RFK to resign. He elaborated on his thinking in his most extensive comments ...

The National Center for Health Statistics divisions lost about 100 people to RIFs. Here's what estimate about 100 jobs were ...

Antitrust regulators in Turkey fined more than a dozen large pharma companies for agreeing not to poach employees from one ...

The risk to the public is low, officials say. These are not the U.S. first cases of what is known as clade I mpox. But all ...

Morning, all. Today, we have more interesting tidbits from the STAT Summit: Eli Lilly’s CSO defends the company’s hiring of ...